HUADONG MEDICINE CO., LTD

Press Releases Huadong Medicine Co., Ltd

Equities

000963

CNE0000011S1

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-28 pm EDT			5-day change	1st Jan Change
32.97 ^CNY	+0.61%		+3.61%	-20.48%

Apr. 25	Huadong Medicine Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 18	Huadong Medicine's 2023 Profit Jumps 14%	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

MC2 Therapeutics and Huadong Announce License, Development and Commercialization Agreement for Wynzora Cream in Greater China	23-09-01	AQ
CARsgen Announced 2023 Interim Results	23-08-23	AQ
Arcutis and Huadong Announce Strategic Collaboration and Licensing Agreement for Topical Roflumilast in Greater China and Southeast Asia	23-08-11	AQ
CARsgen Announced 2022 Annual Results and Business Updates	23-03-23	AQ
Ad hoc announcement inside information pursuant to Article 17 MAR Heidelberg Pharma AG Announces Adjustment of Guidance	22-10-05	AQ
Heidelberg Pharma AG Raises Approximately EUR 80 Million from Capital Measure	22-08-31	AQ
AKSO and Huadong Medicine Announce Strategic Collaboration to Develop and Commercialize AB002 in Asia Pacific Ex-Japan	22-02-09	BU
Huadong Medicine : and Insilico Medicine enter co-development partnership to advance oncology drug discovery by hitting undruggable targets	21-09-08	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer